Literature DB >> 22617546

TRPV4 axonal neuropathy spectrum disorder.

Meriel McEntagart1.   

Abstract

The TRPV4-axonal neuropathy spectrum is a group of disorders presenting as a predominantly motor axonal peripheral neuropathy, frequently in association with vocal cord paralysis, and occasionally accompanied by sensorineural hearing loss and bladder urgency and incontinence. These disorders show autosomal dominant inheritance, variable disease expression and reduced disease penetrance. TRPV4 encodes a calcium-permeable non-selective cation channel of uncertain biological function. Intriguingly, mutations in this gene also underlie a family of autosomal dominant, short-stature skeletal dysplasias. This article reviews the clinical features of the neuropathy spectrum, the emerging neuropathy/skeletal dysplasia overlap disorders and the present knowledge of the impact of mutations in this gene on channel function.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22617546     DOI: 10.1016/j.jocn.2011.12.003

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  11 in total

Review 1.  TRPV4 as a therapeutic target for joint diseases.

Authors:  Amy L McNulty; Holly A Leddy; Wolfgang Liedtke; Farshid Guilak
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-12-18       Impact factor: 3.000

2.  Partial opening and subconductance gating of mechanosensitive ion channels in dystrophic skeletal muscle.

Authors:  Ivan Vasquez; Nhi Tan; Mark Boonyasampant; Kari A Koppitch; Jeffry B Lansman
Journal:  J Physiol       Date:  2012-09-10       Impact factor: 5.182

Review 3.  The puzzle of TRPV4 channelopathies.

Authors:  Bernd Nilius; Thomas Voets
Journal:  EMBO Rep       Date:  2013-01-11       Impact factor: 8.807

4.  Charcot-Marie-Tooth disease type 2C and scapuloperoneal muscular atrophy overlap syndrome in a patient with the R232C TRPV4 mutation.

Authors:  Georgios Koutsis; David Lynch; Andreea Manole; Andreea Manone; Georgia Karadima; Mary M Reilly; Henry Houlden; Marios Panas
Journal:  J Neurol       Date:  2015-06-06       Impact factor: 4.849

5.  Thrombocytosis in an infant with a TRPV4 mutation: a case report.

Authors:  Christopher S Thom; Erik Brandsma; Michele P Lambert
Journal:  Platelets       Date:  2020-04-22       Impact factor: 3.862

Review 6.  Human skeletal dysplasia caused by a constitutive activated transient receptor potential vanilloid 4 (TRPV4) cation channel mutation.

Authors:  Sang Sun Kang; Sung Hwa Shin; Chung-Kyoon Auh; Jaesun Chun
Journal:  Exp Mol Med       Date:  2012-12-31       Impact factor: 8.718

Review 7.  TRPing to the Point of Clarity: Understanding the Function of the Complex TRPV4 Ion Channel.

Authors:  Trine L Toft-Bertelsen; Nanna MacAulay
Journal:  Cells       Date:  2021-01-15       Impact factor: 6.600

8.  Novel mutations highlight the key role of the ankyrin repeat domain in TRPV4-mediated neuropathy.

Authors:  Jeremy M Sullivan; Christina M Zimanyi; William Aisenberg; Breanne Bears; Dong-Hui Chen; John W Day; Thomas D Bird; Carly E Siskind; Rachelle Gaudet; Charlotte J Sumner
Journal:  Neurol Genet       Date:  2015-10-22

9.  Unraveling the mechanism by which TRPV4 mutations cause skeletal dysplasias.

Authors:  Holly A Leddy; Amy L McNulty; Farshid Guilak; Wolfgang Liedtke
Journal:  Rare Dis       Date:  2014-10-30

10.  TRPV4 and TRPM8 as putative targets for chronic low back pain alleviation.

Authors:  Stefania Fozzato; Nicolò Baranzini; Elena Bossi; Raffaella Cinquetti; Annalisa Grimaldi; Paola Campomenosi; Michele Francesco Surace
Journal:  Pflugers Arch       Date:  2020-09-21       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.